Pneumonia claims the lives of more than 800,000 children every year.
Nicoletta Snellen Nicoletta Snellen

Pneumonia claims the lives of more than 800,000 children every year.

It’s frightening and daunting. Each year, pneumonia claims the lives of more than 800,000 children. Baby Francis is the face of all of these children.

Once upon a time, there was an old man who used to go to the ocean to do his writing. He had a habit of walking on the beach every morning before he began his work. Early one morning, he was walking along the shore after a big storm had passed and found the vast beach littered with starfish as far as the eye could see, stretching in both directions.

Read More
A new approach to Oxygen provision
Nicoletta Snellen Nicoletta Snellen

A new approach to Oxygen provision

Our long-term goal is to help reduce mortality from hypoxaemic illnesses, especially in children where the mortality is currently the worst. This means supplying oxygen in the places where it is most needed - the periphery…

Read More
Oxygen can save thousands of children in Africa
Guest User Guest User

Oxygen can save thousands of children in Africa

The leading cause of children’s deaths worldwide is surprising. Pneumonia kills nearly 1 million children under five each year, many of whom are in Africa. Find out how FREO2, a Melbourne based foundation, is supporting remote health centres without reliable electricity to provide oxygen, a life-saving treatment for children with pneumonia or newborns with trouble breathing.

Read More
FREO2 University of Melbourne Pursuit Article
Nicoletta Snellen Nicoletta Snellen

FREO2 University of Melbourne Pursuit Article

In many remote communities around the world, electricity can be intermittent at best and non-existent at worst, but FREO₂ LPOS is delivering oxygen without power and saving children’s lives…

Read More
Guest User Guest User

FREO2 partners up with Sensirion.

We would like to thank Sensirion for their recent collaboration and support of our vision. FREO2 has already started trials with Siphon in Uganda, with further testing soon to follow.

Read More